(Q33382114)

26 July 2017

title

Bone marrow toxicity in HCV genotype 5a-infected patient after peg-IFN alpha-2a and ribavirin therapy (English)

1 reference

26 July 2017

1 reference

C M J Drapeau

1

1 reference

26 July 2017

D Remotti

2

1 reference

26 July 2017

P Noto

3

1 reference

26 July 2017

A Capone

4

1 reference

26 July 2017

E Boumis

5

1 reference

26 July 2017

N Petrosillo

6

1 reference

26 July 2017

language of work or name

1 reference

1 October 2008

1 reference

26 July 2017

published in

Journal of Chemotherapy

1 reference

26 July 2017

volume

20

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

648-651

1 reference

Management of hepatitis C in liver transplant recipients.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

Pegylated-interferon induced severe bone marrow hypoplasia in a patient with multiple myeloma receiving thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.5.648

10.1179/JOC.2008.20.5.648

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference